PLIANT THERAPEUTICS, INC. Shares Outstanding (Cover Page)
PLIANT THERAPEUTICS, INC. (PLRX) had Shares Outstanding (Cover Page) of 61.92 million shares as of 2026-08-07, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-07: Entity Common Stock, Shares Outstanding 61.92M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 61.92M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 61.91M shares.
- 2025-11-01: Entity Common Stock, Shares Outstanding 61.45M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 61.92M shares 10-Q · filed 2026-08-11 |
| 2026-05-08 | 61.92M shares 10-Q · filed 2026-05-11 |
| 2026-03-05 | 61.91M shares 10-K · filed 2026-03-11 |
| 2025-11-01 | 61.45M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 61.39M shares 10-Q · filed 2025-08-07 |
| 2025-05-01 | 61.39M shares 10-Q · filed 2025-05-08 |
| 2025-02-21 | 61.24M shares 10-K · filed 2025-03-03 |
| 2024-11-01 | 60.85M shares 10-Q · filed 2024-11-07 |
| 2024-08-01 | 60.80M shares 10-Q · filed 2024-08-07 |
| 2024-05-01 | 60.33M shares 10-Q · filed 2024-05-06 |
| 2024-02-23 | 60.24M shares 10-K · filed 2024-02-27 |
| 2023-11-03 | 59.90M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 59.83M shares 10-Q · filed 2023-08-09 |
| 2023-05-05 | 59.16M shares 10-Q · filed 2023-05-09 |
| 2023-03-05 | 58.94M shares 10-K · filed 2023-03-09 |
| 2022-11-04 | 48.76M shares 10-Q · filed 2022-11-08 |
| 2022-08-05 | 48.68M shares 10-Q · filed 2022-08-08 |
| 2022-05-06 | 36.17M shares 10-Q · filed 2022-05-09 |
| 2022-02-25 | 36.11M shares 10-K/A · filed 2022-05-27 |
| 2021-11-05 | 36.04M shares 10-Q · filed 2021-11-09 |
| 2021-08-06 | 35.94M shares 10-Q · filed 2021-08-09 |
| 2021-05-06 | 35.89M shares 10-Q · filed 2021-05-10 |
| 2021-03-09 | 35.74M shares 10-K · filed 2021-03-16 |
| 2020-11-07 | 35.48M shares 10-Q · filed 2020-11-10 |
| 2020-08-07 | 35.44M shares 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |